Catalogo Ricerca UNIPD

Catalogo Ricerca UNIPD: [268336] Home page macrotipologia

Sfoglia

01 CONTRIBUTO IN RIVISTA 158976
- 01.01 - Articolo in rivista 147774
- 01.02 - Recensione in rivista 3097
- 01.03 - Scheda bibliografica 450
- 01.04 - Nota a sentenza 871
- 01.05 - Abstract in rivista 6620
- 01.06 - Traduzione in rivista 164

02 CONTRIBUTO IN VOLUME 37423

03 LIBRO 7017
- 03.01 - Monografia o trattato scientifico 6258
- 03.02 - Concordanza 11
- 03.03 - Indice 28
- 03.04 - Bibliografia 55
- 03.05 - Edizione critica di testi/di scavo 195
- 03.06 - Pubblicazioni di fonti inedite 48
- 03.07 - Commento scientifico 145
- 03.08 - Traduzione di libro 277

04 CONTRIBUTO IN ATTO DI CONVEGNO 50515
- 04.01 - Contributo in atti di convegno 37450
- 04.02 - Abstract in atti di convegno 10569
- 04.03 - Poster 2496

05 BREVETTO 658
- 05.01 - Brevetto 658

06 CURATELA 3342
- 06.01 - Curatela 3342

07 ALTRA TIPOLOGIA 2831
- 07.01 - Composizione 7
- 07.02 - Disegno 6
- 07.03 - Design 0
- 07.04 - Performance 11
- 07.05 - Esposizione 20
- 07.06 - Mostra 64
- 07.07 - Manufatto 0
- 07.08 - Prototipo d'arte e relativi progetti 2
- 07.09 - Cartografia 86
- 07.10 - Banche dati 92
- 07.11 - Software 69
- 07.12 - Altro 2472
- 07.13 - Progetto architettonico 2

08 TESI DI DOTTORATO 6558
- 08.01 - Tesi di Dottorato UNIPD (Deposito Legale) 6256
- 08.02 - Altre Tesi di Dottorato 302

09 WORKING PAPER 565
- 09.01 - Working Paper 565

10 RAPPORTO TECNICO 451
- 10.01 - Rapporto tecnico 451

Prodotti recenti

Early Changes in B and Plasma Cell Subsets and Traditional Serological Markers as Predictors of SRI-4 Response to Therapy in Systemic Lupus Erythematosus

With the premise of the hypothesis that early biological responses to therapy for active systemic lupus erythematosus (SLE) portend later clinical improvements, we studied changes in B cell subsets and traditional serological markers in relation to clinical response to standard therapy (ST) with or without the addition of belimumab.

Deletions in VANGL1 are a risk factor for antibody-mediated kidney disease

We identify an intronic deletion in VANGL1 that predisposes to renal injury in high risk populations through a kidney-intrinsic process. Half of all SLE patients develop nephritis, yet the predisposing mechanisms to kidney damage remain poorly understood. There is limited evidence of genetic contribution to specific organ involvement in SLE.1 , 2 We identify a large deletion in intron 7 of Van Gogh Like 1 (VANGL1), which associates with nephritis in SLE patients. The same deletion occurs at i...

Prevalence and death rate of COVID-19 in systemic autoimmune diseases in the first three pandemic waves. Relationship to disease subgroups and ongoing therapies

Autoimmune systemic diseases (ASD) represent a predisposing condition to COVID-19. Our prospective, observational multicenter telephone survey study aimed to investigate the prevalence, prognostic factors, and outcomes of COVID-19 in Italian ASD patients.

Impact of low-dose acetylsalicylic acid on pregnancy outcome in systemic lupus erythematosus: results from a multicentre study

It is still a matter of debate whether low-dose acetylsalicylic acid (LDASA) should be prescribed to all patients with SLE during pregnancy. This study aimed at investigating the impact of LDASA on pregnancy outcomes in patients with SLE without history of renal involvement and without antiphospholipid antibodies (aPL).

Health-related quality of life in patients with mixed connective tissue disease: a comparison with matched systemic sclerosis patients

Health-Related Quality of Life (HRQoL) in adult patients with mixed connective tissue disease (MCTD) has not been described so far. Therefore, we performed an explorative study to evaluate HRQoL in MCTD patients.

Scopri

Accesso al fulltext

no fulltext253437
open14421
reserved255
embargoed222
partially open1